Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Cardiovascular Pharmacotherapeutics Drug Classes PDF full book. Access full book title Cardiovascular Pharmacotherapeutics Drug Classes.
| Author | : Edmund H. Sonnenblick |
| Publisher | : |
| Total Pages | : 942 |
| Release | : 2003 |
| Genre | : Cardiovascular agents |
| ISBN | : 9780071426480 |
| Author | : William H. Frishman, MD |
| Publisher | : Cardiotext Publishing |
| Total Pages | : 798 |
| Release | : 2011-05-11 |
| Genre | : Medical |
| ISBN | : 1935395629 |
Everything practicing physicians and pharmacists need to know about drug therapy for cardiovascular disease. A critically acclaimed classic reference now in its third edition, Cardiovascular Pharmacotherapeutics provides current information regarding the contemporary use of all available cardiovascular medications for adults and children. Strongly emphasizing the scientific rationale behind the use of such therapies in cardiac disease, it discusses new drugs and novel compounds that are under development and may emerge as the cardiac therapies of the future. This edition also addresses special considerations for drug therapy use in the elderly, during pregnancy, and in those with hepatic or renal disease. A generous assortment of tables, figures, and appendices guides readers in their investigations of each drug group and various disease states. This new third edition presents an in-depth discussion of: All cardiovascular agents currently available The scientific basis behind every pharmacotherapy advance Mechanisms of action of cardiovascular pharmacotherapeutics The latest advances in cardiovascular drug therapy Specific drug treatments, and information on recently approved drugs Molecular biological advances Drugs in development Hands-on discussions of how to utilize specific drugs for treatment of various cardiovascular disorders and for the prevention of disease Also included are 8 appendices that provide practical, hands-on information on using drugs in clinical settings, including relevant pharmacokinetic information, and practical drug prescribing information. All updated with an accompanying website, Advances in Cardiovascular Pharmacotherapeutics www.cvpct3.com
| Author | : William H. Frishman |
| Publisher | : McGraw Hill Professional |
| Total Pages | : 820 |
| Release | : 2003-11-13 |
| Genre | : Medical |
| ISBN | : 9780071373630 |
This manual, based on the definitive reference, is a concise and portable guide to the pharmacologic management of cardiovascular conditions. Focused on clinically relevant information related to drug treatment, this book features tables and charts for quick reference.
| Author | : Edmund H. Sonnenblick |
| Publisher | : |
| Total Pages | : 942 |
| Release | : 2003 |
| Genre | : Cardiovascular agents |
| ISBN | : 9780071426497 |
| Author | : Lionel H. Opie |
| Publisher | : Saunders |
| Total Pages | : 0 |
| Release | : 2009 |
| Genre | : Medical |
| ISBN | : 9781416061588 |
Drugs for the Heart presents highly portable, up-to-date information on every drug class used to treat cardiovascular disease. Drs. Lionel H. Opie and Bernard J. Gersh put the latest dosages, interactions, indications and contraindications, side effects, and more at your fingertips, equipping you to make effective clinical decisions on behalf of your patients Quickly check when to use each drug for any condition with the popular "Which Drug for Which Disease" chapter. Get expert advice from the practice-proven experience of two well-known editors who represent the best possible combination of clinical and research expertise in cardiovascular therapeutics. Expedite your reference with summaries of each drug class at the end of chapters. Carry it with you anywhere thanks to a highly compact, pocket-sized format. Navigate the latest pharmacologic advances through coverage of the newest drugs and drug classes, as well as all the latest clinical trial results and evidence used to treat heart disease. Effectively manage comorbid diseases. Apply international insights into cardiac drugs, thanks to new global contributors. Visualize key pharmacologic and physiologic actions thanks to dynamic new full-color drawings. Access the complete contents online at Expert Consult, with regular online updates posted by leading cardiologist, Dr. Opie. Your purchase entitles you to access the web site until the next edition is published, or until the current edition is no longer offered for sale by Elsevier, whichever occurs first. If the next edition is published less than one year after your purchase, you will be entitled to online access for one year from your date of purchase. Elsevier reserves the right to offer a suitable replacement product (such as a downloadable or CD-ROM-based electronic version) should access to the web site be discontinued.
| Author | : Juan Carlos Kaski |
| Publisher | : European Society of Cardiology |
| Total Pages | : 961 |
| Release | : 2019-05-23 |
| Genre | : Medical |
| ISBN | : 0198759932 |
The ESC Handbook on Cardiovascular Pharmacotherapy, based on the most recent guidelines in cardiovascular pharmacology, and containing a comprehensive A-Z formulary of common and less commonly used cardiac drugs and drug groups, provides practical and accessible guidance on all areas of drugprescribing.Previously published as Drugs in Cardiology, this new edition has been developed by the ESC Working Group on Cardiovascular Pharmacology. Pharmacology is an integral aspect in almost all disciplines within cardiology and all cardiologists use cardiovascular drugs.Completely updated and aligned with the ESC Clinical Practice Guidelines for prescribing, this handbook is essential reading for consultants, registrars in training, general practitioners, specialist cardiac nurses and cardiovascular pharmacologists.
| Author | : Lionel H. Opie |
| Publisher | : Elsevier Health Sciences |
| Total Pages | : 513 |
| Release | : 2011-12-01 |
| Genre | : Medical |
| ISBN | : 1455740896 |
The new edition of this market-leading cardiac drug resource equips you with the latest advances in cardiovascular pharmacology, one of the most rapidly changing areas of medicine. It not only offers in-depth information on all of the drug classes used to treat heart disease, but also covers new drug classes, drug use for single and multiple problem management, and more. Dynamic full-color drawings illustrate key pharmacological and physiological actions, and a user-friendly organization directs you to the information you need. An increased emphasis on the practical use of drugs saves you valuable time in researching relevant information. Features the practice-proven experience of two well-known editors who represent the best possible combination of clinical and research expertise in cardiovascular therapeutics. Offers easy-to-access, useful information on when to use each drug—and for what conditions—in a chapter entitled “Which Drug for Which Disease. Discusses the management of single diseases and multiple comorbidities. Summarizes each drug class at the end of chapters to expedite reference. Incorporates all-new drugs, preparations, and clinical trial data in each chapter, equipping you to make the most up-to-date, informed clinical decisions. Offers expanded coverage of comorbid diseases through new chapters on metabolic syndrome, hyperglycemia, and diabetes. Features an increased emphasis on the practical use of drugs through highlighted sections and key illustrations, saving you time in searching for relevant information. Presents the work of several new contributors who represent a broad international perspective to equip you with a global view of cardiovascular pharmacology.
| Author | : William H. Frishman |
| Publisher | : Springer Science & Business Media |
| Total Pages | : 350 |
| Release | : 2013-06-29 |
| Genre | : Medical |
| ISBN | : 146156767X |
The third edition of Current Cardiovascular Drugs is designed to provide an updated practical compendium of current knowledge regarding cardiovascular drug therapy in a concise, easily readable format. The book is organized into chapters by drug class, and details the pharmacologic characteristics of specific treatment entities. The clinical efficacy and limitations of the various drug therapies are discussed using supportive reference material from the most authoritative sources and published clinical trials.
| Author | : Kanu Chatterjee |
| Publisher | : JAYPEE BROTHERS PUBLISHERS |
| Total Pages | : 529 |
| Release | : 2013-12-15 |
| Genre | : Medical |
| ISBN | : 9350907798 |
Doody Rating : 3 stars : Cardiac drugs resource endows with the latest advances in cardiovascular pharmacology. Written by experts in cardiology from world renowned institutes, equipped with global view, signifying the best possible combination of clinical and research expertise in cardiovascular pharmacology. This is a comprehensive drug resource which provides up-to-date information on one of the most rapidly changing areas of medicine. Easy to follow, providing practical advice on how to manage cardiac diseases with a focus on hands-on therapeutic guidance for the clinicians. Text talks about all of the drug-groups useful in various indications like drugs for acute coronary syndromes, dyslipidemia, hypertension, pulmonary hypertension, angina, etc. along with data from clinical trials. This book is exhaustive coverage of newly evolving co-morbid conditions with chapters on metabolic syndrome and pregnancy. Future directions: Pharmacogenomics elaborates on gene interactions with cardiovascular drugs. The unique feature of this book is the detailed discussion on the guidelines of the American College of Cardiology/American Heart Association for the use of pharmacologic agents in various clinical conditions. It is enhanced with four colour illustrations and images, illustrating the key pharmacological and physiological actions. It is useful for cardiologist, pharmacologist, physicians, clinicians and specialist.
| Author | : Institute of Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 280 |
| Release | : 2000-10-03 |
| Genre | : Medical |
| ISBN | : 0309183537 |
The VA National Formulary generated controversy, which motivated congressional scrutiny and a directive to the VA to commission this report reviewing the experience with the National Formulary and formulary system. This Institute of Medicine committee was pleased to assist the Congress with this review, in part because the committee saw in the VHA example an opportunity to understand and anticipate problems that all publicly funded programs are likely to encounter in this new age of pharmaceuticals. The Congress asked the committee to review the restrictiveness of the National Formulary, its impact on the costs and quality of care in the VHA, and how it compared to formularies and drug management practices in the private sector and in other public programs, especially Medicaid. Detailed in the pages that follow, the committee's findings and conclusions on these questions are, the committee believes, highly instructive, though not always in the ways that we anticipated.
